EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review

Aleksander Kwaśny iD, Adam Włodarczyk iD, Damian Ogonowski, Wiesław Jerzy Cubała iD

Pharmaceuticals · 10.04.2023 · 16 (4) · 568

DOI: 10.3390/ph16040568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.04.2023. Verfasst von Aleksander Kwaśny und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, 80-214 Gdańsk, Poland. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gdańsk Medical University, Medical University of Gdańsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression is a debilitating disease with a high socioeconomic burden. Regular antidepressants usually require several weeks to ameliorate symptoms; however, numerous patients do not achieve remission. What is more, sleep disturbances are one of the most common residual symptoms. Ketamine is a novel antidepressant with rapid onset of action with a proven antisuicidal effect. Little is known about its impact on sleep–wake and circadian rhythm alterations. The aim of this systematic review is to research the impact ketamine has on sleep disturbances in depression.

Methods

PubMed, Web of Science, and APA PsycINFO were searched for relevant studies on ketamine’s impact on sleep disturbances in depression. Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA2020 methodology was applied. The systematic review protocol was registered in the PROSPERO Registry (CRD42023387897).

Results

Five studies were included in this review. Two studies reported significant improvement in sleep measured by MADRS (Montgomery–Åsberg Depression Rating Scale) and QIDS-SR16 (Quick Inventory of Depressive Symptomatology Self-Report (16-item)) scales after intravenous ketamine and intranasal esketamine administration. One case report showed mitigation of symptoms in PSQI (Pittsburgh Sleep Quality Index) and ISI (Insomnia Severity Index) during 3-month treatment with esketamine. In two studies, sleep was objectively measured by nocturnal EEG (electroencephalography) and showed a decrease in nocturnal wakefulness accompanied by an increase in slow wave (SWS) and rapid eye movement (REM) sleep.

Conclusion

Ketamine reduces the severity of sleep insomnia in depression. Robust data are lacking. More research is needed.

Schlagwörter

Stichwörter der Autor:innen

arketaminecircadian rhythmdepressionesketaminehypersomniainsomniaketamineketamine metabolitesmajor depressive disorder

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, 80-214 Gdańsk, Poland.

ORCID-Profile: Aleksander Kwaśny, Adam Włodarczyk, Wiesław Jerzy Cubała

Förderung

  • Gdańsk Medical University
  • Medical University of Gdańsk

Zitieren

APA

Kwaśny, A., Włodarczyk, A., Ogonowski, D., & Cubała, W. J. (2023). Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review. Pharmaceuticals, 16(4), 568. https://doi.org/10.3390/ph16040568

Vancouver

Kwaśny A, Włodarczyk A, Ogonowski D, Cubała WJ. Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review. Pharmaceuticals. 2023;16(4):568. doi:10.3390/ph16040568

BibTeX
@article{Kwany2023,
  author = {Kwaśny, Aleksander and Włodarczyk, Adam and Ogonowski, Damian and Cubała, Wiesław Jerzy},
  title = {Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {4},
  pages = {568},
  doi = {10.3390/ph16040568}
}
Kostenlos starten →